StockData
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30

BGM Group Ltd.

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026
$8.97+0.32 (+3.70%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns BGM's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
LX Management Company Limited9,800,00049.00%13D (active)Nov 1, 2024
Innovo Limited8,787,5006.00%13G (passive)Apr 25, 2025
AIX Inc.69,995,66172.00%13D (active)Dec 27, 2024
Low Thia Yang38,165,29020.70%13D (active)May 19, 2025
Zhanchang Xin2,767,80038.30%13D (active) amendmentNov 1, 2024
Zhuojun Feng24,462,50016.80%13G (passive)Apr 25, 2025
Qingyue Limited20,000,00010.90%13G (passive)May 23, 2025
Xing Lai20,000,00010.90%13G (passive)May 22, 2025
CISG Holdings Ltd.16,529,3308.99%13D (active) amendmentMay 23, 2025

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Yaxuan ZHAIChief Financial Officer––May 14, 2026
yuehua renDirector––May 14, 2026
Waihua XuDirector––May 14, 2026
Zefei LouDirector––May 14, 2026
LIN (Henry) ZHANGDirector––Apr 13, 2026